» Articles » PMID: 29872322

Overexpression of MCPH1 Inhibits the Migration and Invasion of Lung Cancer Cells

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2018 Jun 7
PMID 29872322
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of dysfunction of , a recently identified tumor suppressor gene, has not yet been established in lung cancer. In our previous study, it was reported that expression is downregulated in lung cancer tissues and that overexpression inhibits the proliferation of non-small-cell lung cancer cells. The results can be found in the APJC and journals.

Methods: Kaplan-Meier survival analysis was conducted to explore the prognostic significance of MCPH1. Cell experiments were performed to investigate the effects of MCPH1 on the biologic behaviors of lung cancer cells.

Results: In the current study, microarray analysis of MCPH1 revealed that lung cancer patients with high MCPH1 expression had longer relapse-free survival. Overexpression of MCPH1 in A549 lung carcinoma cells successfully inhibited cell migration and invasion. Moreover, overexpression of MCPH1 inhibited migration and invasion by regulating the activities of several proteins that control the epithelial-mesenchymal transition, such as Slug, Snail, E-cadherin, Mdm2, and p53.

Conclusion: Our results indicate that downregulation of MCPH1 correlates with tumor progression in lung cancer, and hence MCPH1 may be an important tumor suppressor gene and a novel candidate therapeutic target in lung cancer.

Citing Articles

TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway.

Lopez M, Fernandez-Mimbrera M, Gollini E, Esteve-Codina A, Sanchez A, Ortega J Sci Rep. 2025; 15(1):3831.

PMID: 39885205 PMC: 11782647. DOI: 10.1038/s41598-025-87895-8.


Loop Extrusion Machinery Impairments in Models and Disease.

Ryzhkova A, Maltseva E, Battulin N, Kabirova E Cells. 2024; 13(22).

PMID: 39594644 PMC: 11592926. DOI: 10.3390/cells13221896.


The emerging role of MCPH1/BRIT1 in carcinogenesis.

Alsolami M, Aboalola D, Malibari D, Alghamdi T, Alshekhi W, Jad H Front Oncol. 2023; 13:1047588.

PMID: 36845691 PMC: 9951231. DOI: 10.3389/fonc.2023.1047588.


Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers.

Yuan J, Jiang X, Lan H, Zhang X, Ding T, Yang F Front Cell Dev Biol. 2022; 9:736649.

PMID: 35111745 PMC: 8803135. DOI: 10.3389/fcell.2021.736649.


METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.

Lee S, Lee K, Kim H, Cho J Int J Mol Sci. 2021; 22(11).

PMID: 34063990 PMC: 8196784. DOI: 10.3390/ijms22115432.


References
1.
Yokoyama K, Kimoto K, Itoh Y, Nakatsuka K, Matsuo N, Yoshioka H . The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2011; 250(1):15-23. PMC: 3262137. DOI: 10.1007/s00417-011-1766-x. View

2.
Mai L, Yi F, Gou X, Zhang J, Wang C, Liu G . The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer. Mol Cell Biochem. 2014; 392(1-2):95-107. DOI: 10.1007/s11010-014-2022-6. View

3.
Rajic J, Inic-Kanada A, Stein E, Dinic S, Schuerer N, Uskokovic A . Infection Is Associated with E-Cadherin Promoter Methylation, Downregulation of E-Cadherin Expression, and Increased Expression of Fibronectin and α-SMA-Implications for Epithelial-Mesenchymal Transition. Front Cell Infect Microbiol. 2017; 7:253. PMC: 5469886. DOI: 10.3389/fcimb.2017.00253. View

4.
Pliarchopoulou K, Voutsinas G, Papaxoinis G, Florou K, Skondra M, Kostaki K . Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett. 2012; 3(6):1301-1306. PMC: 3392588. DOI: 10.3892/ol.2012.665. View

5.
Kruger S, Mottaghy F, Buck A, Maschke S, Kley H, Frechen D . Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging. Nuklearmedizin. 2010; 50(3):101-6. DOI: 10.3413/Nukmed-0338-10-07. View